Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Conditions:   Amyotrophic Lateral Sclerosis;   ALS;   Lou Gehrig Disease;   Lou Gehrig's Disease;   Lou-Gehrigs Disease;   Motor Neuron Disease, Amyotrophic Lateral Sclerosis Intervention:   Drug: Riluzole Sponsor:   Biohaven Pharmaceutical Holding Company Ltd. Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials